> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Oncologic Panel to Vote on Incyte BLA
- URL: https://www.fdaweb.com/oncologic-panel-to-vote-on-incyte-bla/
- Published: 2021-05-14T12:00:00.000Z
- Updated: 2026-09-14T16:58:59.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5149326

*Federal Register* notice: FDA has announced a 6/24 Oncologic Drugs Advisory Committee that will discuss an Incyte BLA for retifanlimab injection. The proposed indication is for treating adult patients with locally advanced or metastatic squamous carcinoma of the anal canal who have progressed on from or who are intolerant of platinum-based chemotherapy. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2021-05-14/pdf/2021-10181.pdf?ref=fdaweb.com).